Woman & Doctor

ENCLEAR THERAPIES

Improving the lives of patients suffering from CNS disease

At EnClear Therapies, our goal is to improve and extend the lives of patients with a wide variety of CNS disease through precision dosing. We are building an Integrated Neurotechnology Business using our CSF Health Platform to create a pipeline of significant near-term, patient focused, opportunities. Launching into neuro-oncology, while leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.

Institutional Partners

wMMI4l8xCdVPboHpnIR9yUpfZu01566910559408_200x200.png
partners-investors-logo-amgen.png
DolbyFamilyVentures-logo-horizontal-color-box-M-white.jpeg
presight.png
Quark_logo.png
2020_logo_Full_19.png

ABOUT ENCLEAR

Our mission is to improve and extend the lives of patients suffering from central nervous system (CNS) disorders such as neurodegenerative diseases and CNS malignancies.

Our opportunity is to utilize our CSF Health Platform to provide precision dosing to areas of the CNS most benefited by both existing & next-generation therapeutics.

Our strategy is two-fold:

1) Launch into neuro oncology, immediately addressing $1.2B market need. 

2) Leverage partnerships to expand our portfolio with next gen, personalized medicine into neurodegenerative, lysosomal storage & autoimmune diseases.

CSF HEALTH PLATFORM

Closed loop CSF control & integrated ML/AI, the EnClear Therapies CSF health platform provides Precision Dosing of CNS based therapeutics to obtain efficacious levels, while reducing risk of severe side effects and peripheral toxicity.

Brain Scans